May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Two Year Experience of Photodynamic Therapy of Age–Related Macular Degeneration in Korea
H. Oh; B.–Y. Ahn; S. Kim; S. Lee; O. Kwon
Author Affiliations & Notes
  • H. Oh
    Ophthalmology, Severance Hospital, Yonsei Univ College of Med, Seoul, Republic of Korea
  • B.–Y. Ahn
    R&D center, EyeGene Inc., Seoul, Republic of Korea
  • S. Kim
    Ophthalmology, Yongdong Severance Hospital, Yonsei Univ College of Med, Seoul, Republic of Korea
  • S. Lee
    Ophthalmology, Severance Hospital, Yonsei Univ College of Med, Seoul, Republic of Korea
  • O. Kwon
    Ophthalmology, Severance Hospital, Yonsei Univ College of Med, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  H. Oh, None; B. Ahn, None; S. Kim, None; S. Lee, None; O. Kwon, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3148. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Two Year Experience of Photodynamic Therapy of Age–Related Macular Degeneration in Korea
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      H. Oh, B.–Y. Ahn, S. Kim, S. Lee, O. Kwon; Two Year Experience of Photodynamic Therapy of Age–Related Macular Degeneration in Korea . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3148.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose:To determine if photodynamic therapy(PDT) with verteporfin can safely reduce the risk of vision loss in patients with subfoveal choroidal neovascularization(CNV) caused by age–related macular degeneration(AMD) in Korea. Methods:We reviewed 67 cases of CNV due to ARMD who was treated by PDT retrospectively. The visual acuity was measured by modified ETDRS chart before and the after treatment. Color and red–free fundus photographs, fluorescein angiography, and indocyanine green angiography were performed and evaluated for lesion character and leakage at every follow–up. Results:Eighty eight percent of patients have occult CNV. Mean visual acuity was 20 letters and mean greatest linear dimension was 3181um. Visual acuity was improved or preserved in 75% after 2–year follow–up. In fluorescein angiography, leakage was increased in 13.1% at 2–year follow–up. Conclusions:The PDT is safe and effective way of treatment for subfoveal CNV caused by AMD.

Keywords: age–related macular degeneration • photodynamic therapy • clinical (human) or epidemiologic studies: outcomes/complications 
© 2004, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept